The Cigna Group
CIHealthcareNASDAQHealthcare Plans · Last scanned Sep 8, 2026
Scan Results
Daily timeframeThe Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. With a market capitalization of $74.65B, it sits in large-cap territory. It operates through two segments: Evernorth Health Services and Cigna Healthcare.
Market Cap
$74.65B
Beta
0.32
P/E (TTM)
11.68
P/E (Fwd)
8.44
EPS (TTM)
$24.18
EPS (Fwd)
$33.49
ROE
16.8%
ROA
4.5%
Cash
$7.26B
Total Debt
$31.88B
Free CF
$7.98B
52W Change
-6.5%
Annual Financials
Cash vs Debt
Where CI stands vs its 150-day and 200-day moving averages
As of the September 1, 2026 close, CI finished 1.32% below its 150-day moving average ($279.77) and 0.52% below its 200-day moving average ($277.52). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CI overbought or oversold?
At the September 1, 2026 close, CI's RSI(14) was 52.8, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The Cigna Group carries $31.88B in total debt against $7.26B in cash reserves — debt is roughly 4.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $7.98B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 16.8%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $179.36B (2022) to $273.85B (2025), reflecting a 53% increase over the period.
CI's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence The Cigna Group's trajectory.